Tue, July 9, 2024

Matthew Sykes Maintained (TWST) at Strong Buy with Increased Target to $55 on, Jul 9th, 2024

Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Strong Buy with Increased Target from $45 to $55 on, Jul 9th, 2024.

Matthew has made no other calls on TWST in the last 4 months.



There are 6 other peers that have a rating on TWST. Out of the 6 peers that are also analyzing TWST, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matthew


  • Luke Sergott of "Barclays" Maintained at Buy with Increased Target to $60 on, Friday, June 28th, 2024
  • Steven Mah of "TD Cowen" Maintained at Strong Buy with Increased Target to $65 on, Thursday, June 13th, 2024
  • Subbu Nambi of "Guggenheim" Initiated at Strong Buy and Held Target at $53 on, Wednesday, June 5th, 2024
  • Sung Ji Nam of "Scotiabank" Maintained at Buy with Increased Target to $48 on, Monday, May 6th, 2024
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Increased Target to $50 on, Friday, May 3rd, 2024
  • Catherine Ramsey of "Baird" Maintained at Buy with Increased Target to $40 on, Friday, May 3rd, 2024